Invitation - Q2 results presentation
(Thomson Reuters ONE) -
Swedish Orphan Biovitrum's interim report for the second quarter 2011 will be
published on July 19 at around 8.30 a.m. CET.
Conference call at 3.00 p.m. CET
Financial analysts and media are invited to a telephone conference at 3.00 p.m.
CET the same day hosted by CEO Kennet Rooth and CFO Lars Sandström. The
presentation will be held in English and can also be followed, directly or
afterwards, via our web sitewww.sobi.com.
Slides used in the presentation will be available in the web cast archive on our
web site prior to the telephone conference.
Details for participation
Please call:
Sweden: +46 (0)8 505 598 53
UK: +44 (0)20 3043 2436
US: +1 866 458 40 87
Yours sincerely,
Åsa Stenqvist,
VP Communications and Investor Relations
Phone: +46 8 697 21 88
About Swedish Orphan Biovitrum (Sobi)
Sobi is a leading European specialty pharmaceutical company focused on providing
and developing specialty pharmaceuticals for patients with rare diseases and
significant medical needs. The portfolio comprises about 60 marketed products,
as well as projects in late clinical phase. Key therapeutic areas are
hematological diseases, autoimmune diseases, hereditary metabolic disorders and
therapeutic oncology. In 2010 Sobi had revenues of SEK 1.9 billion and
approximately 500 employees. The share (STO: SOBI) is listed on NASDAQ OMX
Stockholm. For more information please visitwww.sobi.com
Sobi Press Release July 8, 2011:
http://hugin.info/134557/R/1529598/465121.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1529598]
Unternehmensinformation / Kurzprofil:
Datum: 08.07.2011 - 12:20 Uhr
Sprache: Deutsch
News-ID 56257
Anzahl Zeichen: 2315
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 168 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Invitation - Q2 results presentation"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
